GlobeNewswire Inc.··NaCandel Therapeutics Raises $100M via Public Share Offering
Candel Therapeutics raises $100M via public share offering to fund commercialization of its prostate cancer gene therapy and ongoing lung cancer clinical trials.
CADLFDA approvalclinical trial